First TomoTherapy Hi·Art® Twinned Systems Coming to RISO in the Netherlands
TomoTherapy Incorporated announced today that RISO, the Radiotherapeutic Institute in Deventer, Netherlands will be receiving two twinned systems that will improve radiation therapy treatment productivity and flexibility. The twinned TomoTherapy Hi·Art Systems® will be placed in a new building, currently under construction, in “the Rielerenk”, located in Deventer.
Dr. Fred Robertson, TomoTherapy CEO; Dr. J.J.F.M. Immerzeel, RISO President & Radiation Oncologist; and John Hughes, TomoTherapy VP of Global Sales
As Jack Reese, TomoTherapy Director of European Sales, explains, “The acquisition by RISO of two Hi·Art Systems for their new center in Deventer marks a turning point in cancer patient care. Beyond providing exceptional treatment, twinned systems will allow patients to be easily moved from one machine to the other depending on scheduling needs. Twinning the systems will provide economic benefits to the radiotherapy clinic.” The twinned systems will be used to develop the protocols and tools to treat patients on multiple machines.
Dr. J.J.F.M. Immerzeel, RISO President & Radiation Oncologist, and his staff will be working with TomoTherapy to perfect the process. The emphasis will be on efficient utilization of the equipment. RISO is the first center to receive a set of TomoTherapy twinned systems.
The development of TomoTherapy’s twinned systems marks another achievement for the most advanced method of delivering Image-Guided Intensity Modulated Radiation Therapy (IG/IMRT) today. TomoTherapy’s current customer base has performed over 300,000 CT image-guided patient treatments, an accomplishment that is unprecedented in the industry. RISO will be the first radiation oncology center to offer TomoTherapy’s treatment precision and accuracy to patients in the Netherlands. Delivery is planned for early 2006.
About RISO
RISO (http://www.riso.ws) is an autonomous centre for Radiation Oncology with about 80 employees, serving the regional hospitals in Deventer, Apeldoorn, Zutphen and Coevorden-Hardenberg. RISO`s mission is to offer safe radiotherapeutic care of high quality by employing modern techniques and equipment. In addition to equipment for external irradiation, RISO has at its disposal an apparatus for Brachytherapy, the treatment of prostate cancer being one of the spear points.
25 Jan 2006
